Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 24

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 24
---
) 1,000,000
shares of restricted Common Stock, and (iii) 84,000 shares of Common Stock underlying stock options held by Mr. Silverman that
were vested as of the Record Date or will vest within 60 days thereafter.

<div align='center'>14</div>

(13) Amount consists of (i) 8,315 shares of Common Stock, (ii) 150,000
shares of restricted Common Stock, and (iii) 84,000 shares of Common Stock underlying stock options held by Mr. Walker that
were vested as of the Record Date or will vest within 60 days thereafter.

(14) Amount consists of (i) 76,100 shares of Common Stock underlying
stock options held by Mr. Boctor that were vested as of the Record Date or will vest within 60 days thereafter, (ii) 450,000
shares of restricted Common Stock, (iii) 49,645 shares of Common Stock underlying certain restricted stock units that were vested
as of the Record Date or will vest within 60 days thereafter.

(15) Amount consists of (i) 117 shares of Common Stock, (ii) 150,000
shares of restricted Common Stock, and (iii) 25,000 shares of Common Stock underlying stock options held by Mr. Arnold that
were vested as of the Record Date or will vest within 60 days thereafter.

<div align='center'>15

PROPOSAL NO. 1 - THE ISSUANCE PROPOSAL</div>

Background and Description of the Proposal

On February 17,
2025, the Company entered into that certain Securities Purchase Agreement (the “Purchase Agreement”), by and among the
Company and the investors signatory thereto, pursuant to which, the Company sold in a public offering approximately 13,950,012
shares of the Company’s Common Stock (and 26,049,988 pre-funded warrants (the “Pre-Funded Warrants”) in lieu
thereof), with each share of Common Stock (or Pre-Funded Warrant) accompanied by a Series A Warrant (the “Series A
Warrants”) to purchase 0.25 share of Common Stock (the “Series A Warrant Shares”) and Series B Warrant
(the “Series B Warrants” and, together with the Series A Warrants, the “Series Warrants”) to
purchase one share of Common Stock (the “Series B Warrant Shares” and, together with